A real world multicenter study of first (1L) and second (2L) line treatment patterns and outcomes in advanced pancreatic cancer (APC).

被引:1
作者
Cheung, Winson Y.
Zhang, Hanbo
Tang, Patricia A.
Spratlin, Jennifer L.
Lee-Ying, Richard M.
Goodwin, Rachel Anne
Meyers, Brandon Matthew
Armstrong, Dawn Elizabeth
Ramjeesingh, Ravi
Vickers, Michael M.
Kim, Christina
机构
[1] Univ Calgary Tom Baker Canc Ctr, Calgary, AB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] Cross Canc Inst, Edmonton, AB, Canada
[4] Natl Canc Inst Canada Clin Trials Grp, Ottawa Hosp, Ottawa, ON, Canada
[5] McMaster Univ, Juravinski Canc Ctr, Hamilton, ON, Canada
[6] Dr H Bliss Murphy Canc Ctr, St John, NF, Canada
[7] Nova Scotia Canc Ctr, Dalhousie Univ, Nova Scotia, NS, Canada
[8] Univ Ottawa, Ottawa, ON, Canada
[9] Canc Care Manitoba, Winnipeg, MB, Canada
关键词
D O I
10.1200/JCO.2018.36.4_suppl.476
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
476
引用
收藏
页数:1
相关论文
empty
未找到相关数据